{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T17:28:45Z","timestamp":1760549325900},"reference-count":118,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2013,5,1]],"date-time":"2013-05-01T00:00:00Z","timestamp":1367366400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Translational Research"],"published-print":{"date-parts":[[2013,5]]},"DOI":"10.1016\/j.trsl.2012.12.012","type":"journal-article","created":{"date-parts":[[2013,1,16]],"date-time":"2013-01-16T04:00:36Z","timestamp":1358308836000},"page":"430-440","source":"Crossref","is-referenced-by-count":17,"title":["Drug-induced severe adverse reaction enhanced by human herpes virus-6 reactivation"],"prefix":"10.1016","volume":"161","author":[{"given":"Manuela G.","family":"Neuman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kristi K.","family":"McKinney","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Radu M.","family":"Nanau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vincent","family":"Kong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Izabella","family":"Malkiewicz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tony","family":"Mazulli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"George","family":"Moussa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lawrence B.","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.trsl.2012.12.012_bib1","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1353\/pbm.1968.0004","article-title":"The spectrum of hepatotoxicity","volume":"12","author":"Zimmerman","year":"1968","journal-title":"Perspect Biol Med"},{"key":"10.1016\/j.trsl.2012.12.012_bib2","unstructured":"International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use, 1994.\u00a0Available at: http:\/\/www.ich.org\/fileadmin\/Public_Web_Site\/ICH_Products\/Guidelines\/Efficacy\/E2A\/Step4\/E2A_Guideline.pdf. Accessed July 23,\u00a02012."},{"key":"10.1016\/j.trsl.2012.12.012_bib3","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1067\/mai.2001.118509","article-title":"Drug metabolism, danger signals, and drug-induced hypersensitivity","volume":"108","author":"Gruchalla","year":"2001","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.trsl.2012.12.012_bib4","doi-asserted-by":"crossref","first-page":"577","DOI":"10.5414\/CP201514","article-title":"Adverse drug reactions (ADRs) associated with hospital admissions - elderly female patients are at highest risk","volume":"49","author":"Hofer-Dueckelmann","year":"2011","journal-title":"Int J Clin Pharmacol Ther"},{"key":"10.1016\/j.trsl.2012.12.012_bib5","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1007\/s00228-011-1183-4","article-title":"Risk factors associated with adverse drug reactions in hospitalised children: international multicentre study","volume":"68","author":"Rashed","year":"2012","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.trsl.2012.12.012_bib6","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1002\/pds.3197","article-title":"Electronic healthcare databases for active drug safety surveillance: is there enough leverage?","volume":"21","author":"Coloma","year":"2012","journal-title":"Pharmacoepidemiol Drug Safety"},{"key":"10.1016\/j.trsl.2012.12.012_bib7","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1111\/j.1365-2834.2011.01216.x","article-title":"Multiple drug exposure as a risk factor for the seriousness of adverse drug reactions","volume":"19","author":"Macedo","year":"2011","journal-title":"J Nurs Manag"},{"key":"10.1016\/j.trsl.2012.12.012_bib8","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1111\/j.1365-2125.2010.03774.x","article-title":"Epidemiology and risk factors for drug allergy","volume":"71","author":"Thong","year":"2011","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.trsl.2012.12.012_bib9","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1172\/JCI113798","article-title":"Anticonvulsant hypersensitivity syndrome. In\u00a0vitro assessment of risk","volume":"82","author":"Shear","year":"1988","journal-title":"J Clin Invest"},{"key":"10.1016\/j.trsl.2012.12.012_bib10","series-title":"Hepatotoxicity: the adverse effects of drugs and other chemicals on the liver","year":"1999"},{"key":"10.1016\/j.trsl.2012.12.012_bib11","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/S0009-9120(00)00146-6","article-title":"A novel lymphocyte toxicity assay to assess drug hypersensitivity syndromes","volume":"33","author":"Neuman","year":"2000","journal-title":"Clin Biochem"},{"key":"10.1016\/j.trsl.2012.12.012_bib12","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1097\/00007691-200212000-00008","article-title":"Monitoring adverse drug reactions to sulfonamide antibiotics in human immunodeficiency virus-infected individuals","volume":"24","author":"Neuman","year":"2002","journal-title":"Ther Drug Monit"},{"key":"10.1016\/j.trsl.2012.12.012_bib13","doi-asserted-by":"crossref","first-page":"289","DOI":"10.2174\/157488606777934459","article-title":"Antiepileptic drug-induced hypersensitivity syndrome reactions","volume":"1","author":"Krivoy","year":"2006","journal-title":"Curr Drug Saf"},{"key":"10.1016\/j.trsl.2012.12.012_bib14","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.trsl.2006.12.005","article-title":"Apoptosis in ibuprofen-induced Stevens-Johnson syndrome","volume":"149","author":"Neuman","year":"2007","journal-title":"Transl Res"},{"key":"10.1016\/j.trsl.2012.12.012_bib15","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.trsl.2006.12.001","article-title":"Immunopathogenesis of hypersensitivity syndrome reactions to sulfonamides","volume":"149","author":"Neuman","year":"2007","journal-title":"Transl Res"},{"key":"10.1016\/j.trsl.2012.12.012_bib16","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1111\/j.1600-0625.2008.00748.x","article-title":"Predicting possible zonisamide hypersensitivity syndrome","volume":"17","author":"Neuman","year":"2008","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.trsl.2012.12.012_bib17","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.trsl.2010.01.005","article-title":"Ibuprofen-induced hypersensitivity syndrome","volume":"155","author":"Nanau","year":"2010","journal-title":"Transl Res"},{"key":"10.1016\/j.trsl.2012.12.012_bib18","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.trsl.2012.01.004","article-title":"Genetic and immune predictors for hypersensitivity syndrome to antiepileptic drugs","volume":"159","author":"Neuman","year":"2012","journal-title":"Transl Res"},{"key":"10.1016\/j.trsl.2012.12.012_bib19","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1016\/j.amjmed.2011.01.017","article-title":"The DRESS syndrome: a literature review","volume":"124","author":"Cacoub","year":"2011","journal-title":"Am J Med"},{"key":"10.1016\/j.trsl.2012.12.012_bib20","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1001\/archderm.1995.01690170041005","article-title":"Erythema multiforme with mucous membrane involvement and Stevens-Johnson syndrome are clinically different disorders with distinct causes","volume":"131","author":"Assier","year":"1995","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.trsl.2012.12.012_bib21","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1056\/NEJM199512143332404","article-title":"Medication use and the risk of Stevens-Johnson syndrome or toxic epidermal necrolysis","volume":"333","author":"Roujeau","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1016\/j.trsl.2012.12.012_bib22","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1038\/sj.jid.5701033","article-title":"Stevens-Johnson syndrome and toxic epidermal necrolysis: assessment of medication risks with emphasis on recently marketed drugs. The Euro-SCAR-Study","volume":"128","author":"Mockenhaupt","year":"2008","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.trsl.2012.12.012_bib23","series-title":"Hepatotoxicity: the adverse effects of drugs and other chemicals on the liver","first-page":"353","year":"1978"},{"key":"10.1016\/j.trsl.2012.12.012_bib24","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/0950-3528(88)90012-7","article-title":"Drug-induced and toxic granulomatous hepatitis","volume":"2","author":"Ishak","year":"1986","journal-title":"Baillere\u2019s Clin Gastroenterol"},{"key":"10.1016\/j.trsl.2012.12.012_bib25","series-title":"Diseases of the liver","first-page":"707","article-title":"Toxic and drug-induced hepatitis","author":"Zimmerman","year":"1993"},{"key":"10.1016\/j.trsl.2012.12.012_bib26","series-title":"Drug-induced liver disease","year":"1994"},{"key":"10.1016\/j.trsl.2012.12.012_bib27","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/S0889-8553(21)00227-2","article-title":"Morphologic spectrum of drug-induced hepatic disease","volume":"24","author":"Ishak","year":"1995","journal-title":"Gastroenterol Clin North Am"},{"key":"10.1016\/j.trsl.2012.12.012_bib28","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1212\/WNL.29.11.1480","article-title":"Phenytoin hypersensitivity: 38 cases","volume":"29","author":"Haruda","year":"1979","journal-title":"Neurology"},{"key":"10.1016\/j.trsl.2012.12.012_bib29","first-page":"78","article-title":"Carbamazepine hepatotoxicity: clinical and histopathological features","volume":"74","author":"Bertram","year":"1980","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.trsl.2012.12.012_bib30","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1111\/j.0954-6820.1981.tb09826.x","article-title":"Fatal carbamazepine-associated hepatitis: Report of two cases","volume":"210","author":"Hopen","year":"1981","journal-title":"Acta Med Scand"},{"key":"10.1016\/j.trsl.2012.12.012_bib31","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1002\/hep.1840020513","article-title":"Valproate-induced hepatic injury: analyses of 23 fatal cases","volume":"2","author":"Zimmerman","year":"1982","journal-title":"Hepatology"},{"key":"10.1016\/j.trsl.2012.12.012_bib32","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/1059-1311(92)90003-J","article-title":"Fatal liver failure following generalized tonic- clonic seizures","volume":"1","author":"Brown","year":"1992","journal-title":"Seizure"},{"key":"10.1016\/j.trsl.2012.12.012_bib33","series-title":"Chronic toxicity of antiepileptic drugs","first-page":"1","article-title":"Hepatotoxicity of antiepileptic drugs","author":"Jeavons","year":"1993"},{"key":"10.1016\/j.trsl.2012.12.012_bib34","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1111\/j.1528-1157.1995.tb01618.x","article-title":"Reduction of plasma alanine aminotransferase during vigabatrin treatment","volume":"36","author":"Foletti","year":"1995","journal-title":"Epilepsia"},{"key":"10.1016\/j.trsl.2012.12.012_bib35","first-page":"301","article-title":"Association of human herpesvirus 6 infection with drug reaction with eosinophilia and systemic symptoms","volume":"137","author":"Descamps","year":"2001","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.trsl.2012.12.012_bib36","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1111\/j.1365-2133.2006.07332.x","article-title":"Reactivation of human herpesvirus (HHV) family members other than HHV-6 in drug-induced hypersensitivity syndrome","volume":"155","author":"Seishima","year":"2006","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.trsl.2012.12.012_bib37","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1001\/archderm.145.1.67","article-title":"Twelve-year analysis of severe cases of drug reaction with eosinophilia and systemic symptoms: a cause of unpredictable multiorgan failure","volume":"145","author":"Eshki","year":"2009","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.trsl.2012.12.012_bib38","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1111\/j.1346-8138.2010.01176.x","article-title":"New aspects of drug-induced hypersensitivity syndrome","volume":"38","author":"Tohyama","year":"2011","journal-title":"J Dermatol"},{"key":"10.1016\/j.trsl.2012.12.012_bib39","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.jaad.2004.05.006","article-title":"Clinical implications of in\u00a0vitro drug-induced interferon gamma release from peripheral blood lymphocytes in cutaneous adverse drug reactions","volume":"52","author":"Halevy","year":"2005","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.trsl.2012.12.012_bib40","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1111\/j.1365-2133.2007.08167.x","article-title":"Association of human herpesvirus 6 reactivation with the flaring and severity of drug-induced hypersensitivity syndrome","volume":"157","author":"Tohyama","year":"2007","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.trsl.2012.12.012_bib41","series-title":"Drug hypersensitivity","first-page":"224","article-title":"Drug-induced hypersensitivity syndrome and viral reactivation","author":"Shiohara","year":"2007"},{"key":"10.1016\/j.trsl.2012.12.012_bib42","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1089\/apc.1998.12.833","article-title":"A practitioner\u2019s guide to human herpesvirus-6 (HHV-6) and human herpesvirus-7 (HHV-7)","volume":"12","author":"Caserta","year":"1998","journal-title":"AIDS Patient Care STDS"},{"key":"10.1016\/j.trsl.2012.12.012_bib43","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1159\/000096200","article-title":"Drug-induced hypersensitivity syndrome due to mexiletine hydrochloride associated with reactivation of human herpesvirus 7","volume":"213","author":"Yagami","year":"2006","journal-title":"Dermatology"},{"key":"10.1016\/j.trsl.2012.12.012_bib44","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1002\/jmv.21143","article-title":"Human herpesvirus-6 infection: a prospective study evaluating HHV-6 DNA levels in liver from children with acute liver failure","volume":"80","author":"Chevret","year":"2008","journal-title":"J\u00a0Med Virol"},{"key":"10.1016\/j.trsl.2012.12.012_bib45","first-page":"28","article-title":"Importance of chromosomally integrated HHV-6A and -6B in the diagnosis of active HHV-6 infection","volume":"15","author":"Clark","year":"2008","journal-title":"Herpes"},{"key":"10.1016\/j.trsl.2012.12.012_bib46","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1001\/archderm.140.2.183","article-title":"Association between anticonvulsant hypersensitivity syndrome and human herpesvirus 6 reactivation and hypogammaglobulinemia","volume":"140","author":"Kano","year":"2004","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.trsl.2012.12.012_bib47","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/j.jaad.2006.02.050","article-title":"Hypogammaglobulinemia as an early sign of drug-induced hypersensitivity syndrome","volume":"55","author":"Kano","year":"2006","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.trsl.2012.12.012_bib48","doi-asserted-by":"crossref","first-page":"723062","DOI":"10.1155\/2012\/723062","article-title":"The link between hypersensitivity syndrome reaction development and human herpes virus-6 reactivation","volume":"2012","author":"Pritchett","year":"2012","journal-title":"Int J Hepatol"},{"key":"10.1016\/j.trsl.2012.12.012_bib49","doi-asserted-by":"crossref","first-page":"187","DOI":"10.2165\/00002018-200326030-00004","article-title":"Safety of celecoxib in individuals allergic to sulfonamide: a pilot study","volume":"26","author":"Shapiro","year":"2003","journal-title":"Drug Saf"},{"key":"10.1016\/j.trsl.2012.12.012_bib50","doi-asserted-by":"crossref","DOI":"10.1111\/j.1468-3083.2012.04547.x","article-title":"Clinical course of drug-induced hypersensitivity syndrome treated without systemic corticosteroids","author":"Uhara","year":"2012","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.trsl.2012.12.012_bib51","doi-asserted-by":"crossref","first-page":"355","DOI":"10.2165\/00003088-198815060-00001","article-title":"Clinical pharmacokinetics of doxycycline and minocycline","volume":"15","author":"Saivin","year":"1988","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.trsl.2012.12.012_bib52","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1093\/jac\/dkl224","article-title":"Pharmacokinetics and pharmacodynamics of the tetracyclines including glycylcyclines","volume":"58","author":"Agwuh","year":"2006","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.trsl.2012.12.012_bib53","series-title":"Kucers\u2019 the use of antibiotics","first-page":"851","article-title":"Doxycycline","author":"Eisen","year":"2010"},{"key":"10.1016\/j.trsl.2012.12.012_bib54","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1002\/jps.2600700230","article-title":"Evidence for metabolic inertness of doxycycline","volume":"70","author":"Nelis","year":"1981","journal-title":"J Pharm Sci"},{"key":"10.1016\/j.trsl.2012.12.012_bib55","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1097\/00007691-198206000-00001","article-title":"Doxycycline","volume":"4","author":"Cunha","year":"1982","journal-title":"Therapeutic Drug Monitoring"},{"key":"10.1016\/j.trsl.2012.12.012_bib56","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S0378-4347(00)84428-X","article-title":"Analysis and quantitation of a metabolite of doxycycline in mice, rats, and humans by high-performance liquid chromatography","volume":"274","author":"B\u00f6cker","year":"1983","journal-title":"J Chromatogr"},{"key":"10.1016\/j.trsl.2012.12.012_bib57","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1016\/j.bbrc.2004.08.187","article-title":"4-Epidoxycycline: an alternative to doxycycline to control gene expression in conditional mouse models","volume":"323","author":"Eger","year":"2004","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.trsl.2012.12.012_bib58","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1001\/archinte.1997.00440340035003","article-title":"Doxycycline revisited","volume":"157","author":"Joshi","year":"1997","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.trsl.2012.12.012_bib59","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1038\/ki.1974.52","article-title":"Doxycycline pharmacokinetics in the absence of renal function","volume":"5","author":"Whelton","year":"1974","journal-title":"Kidney Int"},{"key":"10.1016\/j.trsl.2012.12.012_bib60","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1111\/j.1365-2133.2012.10845.x","article-title":"Comparative analysis of adverse drug reactions to tetracyclines: results\u00a0of a French national survey and review of the literature","volume":"166","author":"Lebrun-Vignes","year":"2012","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.trsl.2012.12.012_bib61","doi-asserted-by":"crossref","first-page":"821","DOI":"10.2165\/11592780-000000000-00000","article-title":"Drug-induced photosensitivity: culprit drugs, management and prevention","volume":"34","author":"Drucker","year":"2011","journal-title":"Drug Saf"},{"key":"10.1016\/j.trsl.2012.12.012_bib62","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1111\/j.1365-2230.1993.tb02242.x","article-title":"Phototoxic eruptions due to doxycycline\u2013a dose-related phenomenon","volume":"18","author":"Layton","year":"1993","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.trsl.2012.12.012_bib63","doi-asserted-by":"crossref","first-page":"734","DOI":"10.2340\/00015555-1161","article-title":"Photoallergic erythroderma due to doxycycline therapy of erythema chronicum migrans","volume":"91","author":"Kuznetsov","year":"2011","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.trsl.2012.12.012_bib64","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1358\/dot.2007.43.1.1025697","article-title":"Update on rosacea and anti-inflammatory-dose doxycycline","volume":"43","author":"Berman","year":"2007","journal-title":"Drugs Today (Barc)"},{"key":"10.1016\/j.trsl.2012.12.012_bib65","doi-asserted-by":"crossref","first-page":"3","DOI":"10.5070\/D398Z6B5VT","article-title":"Drug-induced subacute cutaneous lupus erythematosus related to doxycycline","volume":"17","author":"Miller","year":"2011","journal-title":"Dermatol Online J"},{"key":"10.1016\/j.trsl.2012.12.012_bib66","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1159\/000247308","article-title":"Acute generalized exanthematous pustulosis due to doxycycline","volume":"186","author":"Tr\u00fceb","year":"1993","journal-title":"Dermatology"},{"key":"10.1016\/j.trsl.2012.12.012_bib67","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1080\/09546630701759561","article-title":"Doxycycline-induced fixed drug eruption","volume":"19","author":"Gul","year":"2008","journal-title":"J Dermatolog Treat"},{"key":"10.1016\/j.trsl.2012.12.012_bib68","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1046\/j.1365-2230.1999.00436.x","article-title":"Genital fixed drug eruption: cross-reactivity between doxycycline and minocycline","volume":"24","author":"Correia","year":"1999","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.trsl.2012.12.012_bib69","first-page":"207","article-title":"Fixed drug eruption due to doxycycline and metronidazole","volume":"69","author":"Walfish","year":"2002","journal-title":"Cutis"},{"key":"10.1016\/j.trsl.2012.12.012_bib70","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1159\/000119753","article-title":"Severe drug hypersensitivity reaction in a young woman treated with doxycycline","volume":"217","author":"Robles","year":"2008","journal-title":"Dermatology"},{"key":"10.1016\/j.trsl.2012.12.012_bib71","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.annder.2009.10.180","article-title":"Severe drug hypersensitivity reaction (DRESS syndrome) to doxycycline","volume":"137","author":"Mailhol","year":"2010","journal-title":"Ann Dermatol Venereol"},{"key":"10.1016\/j.trsl.2012.12.012_bib72","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1111\/j.1365-2230.2009.03718.x","article-title":"Stevens-Johnson syndrome and toxic epidermal necrolysis due to anticonvulsants share certain clinical and laboratory features with drug-induced hypersensitivity syndrome, despite differences in cutaneous presentations","volume":"35","author":"Teraki","year":"2010","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.trsl.2012.12.012_bib73","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1111\/j.1525-1470.1995.tb00149.x","article-title":"Clinical pattern of cutaneous drug eruption among children and adolescents in north India","volume":"12","author":"Sharma","year":"1995","journal-title":"Pediatr Dermatol"},{"key":"10.1016\/j.trsl.2012.12.012_bib74","doi-asserted-by":"crossref","first-page":"80","DOI":"10.4103\/0378-6323.38431","article-title":"Clinical study of cutaneous drug eruptions in 200 patients","volume":"74","author":"Raksha","year":"2008","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"10.1016\/j.trsl.2012.12.012_bib75","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1097\/PEC.0b013e3181b0a49a","article-title":"Stevens-Johnson syndrome and toxic epidermal necrolysis: consequence of treatment of an emerging pathogen","volume":"25","author":"Mistry","year":"2009","journal-title":"Pediatr Emerg Care"},{"key":"10.1016\/j.trsl.2012.12.012_bib76","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.jaad.2008.11.884","article-title":"Seasonal variation of Stevens-Johnson syndrome and toxic epidermal necrolysis associated with trimethoprim-sulfamethoxazole","volume":"60","author":"Wanat","year":"2009","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.trsl.2012.12.012_bib77","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1111\/j.1365-4632.2010.04481.x","article-title":"Cutaneous adverse drug reactions seen in a tertiary hospital in Johor, Malaysia","volume":"49","author":"Ding","year":"2010","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.trsl.2012.12.012_bib78","doi-asserted-by":"crossref","first-page":"49","DOI":"10.2165\/11593240-000000000-00000","article-title":"Incidence of toxic epidermal necrolysis and Stevens-Johnson Syndrome in an HIV cohort: an observational, retrospective case series study","volume":"13","author":"Mittmann","year":"2012","journal-title":"Am J Clin Dermatol"},{"key":"10.1016\/j.trsl.2012.12.012_bib79","first-page":"119","article-title":"Stevens-Johnson syndrome induced by doxycycline","volume":"79","author":"Cac","year":"2007","journal-title":"Cutis"},{"key":"10.1016\/j.trsl.2012.12.012_bib80","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1097\/ICO.0b013e3181f05773","article-title":"A case report of doxycycline-induced Stevens-Johnson syndrome","volume":"30","author":"Lau","year":"2011","journal-title":"Cornea"},{"key":"10.1016\/j.trsl.2012.12.012_bib81","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.revmed.2006.01.018","article-title":"Human herpesvirus 6 encephalitis in trimethoprim-sulfamethoxazole-induced hypersensitivity syndrome","volume":"27","author":"Mohammedi","year":"2006","journal-title":"Rev Med Intern"},{"key":"10.1016\/j.trsl.2012.12.012_bib82","doi-asserted-by":"crossref","first-page":"101","DOI":"10.2169\/internalmedicine.45.1352","article-title":"Trimethoprim-sulfamethoxazole-induced hypersensitivity syndrome associated with reactivation of human herpesvirus-6","volume":"45","author":"Morimoto","year":"2006","journal-title":"Intern Med"},{"key":"10.1016\/j.trsl.2012.12.012_bib83","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1159\/000324506","article-title":"Association of immunologically confirmed delayed drug reaction and human herpesvirus 6 viremia in a pediatric case of drug-induced hypersensitivity syndrome","volume":"222","author":"Hubiche","year":"2011","journal-title":"Dermatology"},{"key":"10.1016\/j.trsl.2012.12.012_bib84","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1111\/j.1365-4632.2007.03255.x","article-title":"DRESS syndrome caused by teicoplanin and vancomycin, associated with reactivation of human herpesvirus-6","volume":"46","author":"Tamagawa-Mineoka","year":"2007","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.trsl.2012.12.012_bib85","first-page":"307","article-title":"Cytokines-central factors in alcoholic liver disease","volume":"27","author":"Neuman","year":"2003","journal-title":"Alcohol Res Health"},{"key":"10.1016\/j.trsl.2012.12.012_bib86","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1111\/j.1365-2893.2005.00634.x","article-title":"Cytokine profile of peripheral blood mononuclear cells from patients with different outcomes of hepatitis C virus infection","volume":"12","author":"Gramenzi","year":"2005","journal-title":"J Viral Hepatitis"},{"key":"10.1016\/j.trsl.2012.12.012_bib87","doi-asserted-by":"crossref","first-page":"6624","DOI":"10.3748\/wjg.v11.i42.6624","article-title":"Cytokine profile in Egyptian hepatitis C virus genotype-4 in relation to liver disease progression","volume":"11","author":"Zekri","year":"2005","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.trsl.2012.12.012_bib88","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.3748\/wjg.v12.i13.2065","article-title":"Oxidative damage, pro-inflammatory cytokines, TGF-\u03b1 and c-myc in chronic HCV-related hepatitis and cirrhosis","volume":"12","author":"Farinati","year":"2006","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.trsl.2012.12.012_bib89","doi-asserted-by":"crossref","first-page":"3245","DOI":"10.4049\/jimmunol.152.7.3245","article-title":"Class I-restricted cytotoxic T lymphocytes are directly cytopathic for their target cells in\u00a0vivo","volume":"152","author":"Ando","year":"1994","journal-title":"J Immunol"},{"key":"10.1016\/j.trsl.2012.12.012_bib90","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/S0952-7915(96)80034-3","article-title":"To kill or to cure: options in host defense against viral infection","volume":"8","author":"Guidotti","year":"1996","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.trsl.2012.12.012_bib91","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1146\/annurev.immunol.19.1.65","article-title":"Noncytolytic control of viral infections by the innate and adaptive immune response","volume":"19","author":"Guidotti","year":"2001","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.trsl.2012.12.012_bib92","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1002\/hep.20767","article-title":"Intrahepatic gene expression profiles and alpha smooth muscle actin patterns in hepatitis C virus induced fibrosis","volume":"42","author":"Lau","year":"2005","journal-title":"Hepatology"},{"key":"10.1016\/j.trsl.2012.12.012_bib93","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.antiviral.2005.12.001","article-title":"A target on the move: innate and adaptive immune escape strategies of hepatitis C virus","volume":"69","author":"Thimme","year":"2006","journal-title":"Antiviral Res"},{"key":"10.1016\/j.trsl.2012.12.012_bib94","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/j.cyto.2011.08.039","article-title":"Effects of low-dose doxycycline on cytokine secretion in human monocytes stimulated with Aggregatibacter actinomycetemcomitans","volume":"56","author":"Bostanci","year":"2011","journal-title":"Cytokine"},{"key":"10.1016\/j.trsl.2012.12.012_bib95","doi-asserted-by":"crossref","first-page":"370872","DOI":"10.1155\/2011\/370872","article-title":"Modulation of cytokine and cytokine receptor\/antagonist by treatment with doxycycline and tetracycline in patients with dengue fever","volume":"2011","author":"Castro","year":"2011","journal-title":"Clin Dev Immunol"},{"key":"10.1016\/j.trsl.2012.12.012_bib96","first-page":"70","article-title":"Analysis of cytotoxicity induced by proinflammatory cytokines in the human alveolar epithelial cell line A549","volume":"6","author":"Muroya","year":"2012","journal-title":"Biosci Trends"},{"key":"10.1016\/j.trsl.2012.12.012_bib97","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1159\/000100880","volume":"214","author":"Quaglino","year":"2007","journal-title":"Dermatology"},{"key":"10.1016\/j.trsl.2012.12.012_bib98","doi-asserted-by":"crossref","first-page":"938","DOI":"10.3346\/jkms.2011.26.7.938","article-title":"Interleukin-17 in various ocular surface inflammatory diseases","volume":"26","author":"Kang","year":"2011","journal-title":"J Korean Med Sci"},{"key":"10.1016\/j.trsl.2012.12.012_bib99","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1016\/S0002-9440(10)64284-8","article-title":"Toxic epidermal necrolysis and Stevens-Johnson syndrome are induced by soluble Fas ligand","volume":"162","author":"Abe","year":"2003","journal-title":"Am J Pathol"},{"key":"10.1016\/j.trsl.2012.12.012_bib100","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1016\/j.jaci.2008.06.013","article-title":"Increased soluble Fas ligand levels in patients with Stevens-Johnson syndrome and toxic epidermal necrolysis preceding skin detachment","volume":"122","author":"Murata","year":"2008","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.trsl.2012.12.012_bib101","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/j.jaci.2009.01.064","article-title":"The influence of hepatic damage on serum soluble Fas ligand levels of patients with drug rashes","volume":"123","author":"Tohyama","year":"2009","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.trsl.2012.12.012_bib102","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1111\/j.1365-4632.2010.04625.x","article-title":"Prurigo pigmentosa: a clinicopathological study and analysis of associated factors","volume":"50","author":"Lu","year":"2011","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.trsl.2012.12.012_bib103","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1016\/j.intimp.2011.03.011","article-title":"Doxycycline up-regulates the expression of IL-6 and GM-CSF via MAPK\/ERK and NF-\u03baB pathways in mouse thymic epithelial cells","volume":"11","author":"Huang","year":"2011","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.trsl.2012.12.012_bib104","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1126\/scitranslmed.3001116","article-title":"Drug reaction with eosinophilia and systemic symptoms (DRESS): a multiorgan antiviral T cell response","volume":"2","author":"Picard","year":"2010","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.trsl.2012.12.012_bib105","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1001\/archderm.148.4.dlt120002-c","article-title":"Poor benefit\/risk balance of intravenous immunoglobulins in DRESS","volume":"148","author":"Joly","year":"2012","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.trsl.2012.12.012_bib106","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.jaci.2010.06.004","article-title":"Fluctuation of blood and skin plasmacytoid dendritic cells in drug-induced hypersensitivity syndrome","volume":"126","author":"Sugita","year":"2010","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.trsl.2012.12.012_bib107","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1046\/j.1365-2133.2003.05368.x","article-title":"Carbamazepine-induced hypersensitivity syndrome associated with transient hypogammaglobulinaemia and reactivation of human herpesvirus 6 infection demonstrated by real-time quantitative polymerase chain reaction","volume":"149","author":"Aihara","year":"2003","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.trsl.2012.12.012_bib108","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1111\/j.1442-200x.2005.02143.x","article-title":"Different patterns of cytokines, ECP and immunoglobulin profiles at two\u00a0adverse drug reactions in a patient","volume":"47","author":"Aihara","year":"2005","journal-title":"Pediatr Int"},{"key":"10.1016\/j.trsl.2012.12.012_bib109","doi-asserted-by":"crossref","first-page":"S231","DOI":"10.1016\/j.jaad.2005.03.003","article-title":"Clomipramine-induced hypersensitivity syndrome with unusual clinical features","volume":"53","author":"Nishimura","year":"2005","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.trsl.2012.12.012_bib110","doi-asserted-by":"crossref","first-page":"181","DOI":"10.4049\/jimmunol.149.1.181","article-title":"Modulatory effects of Epstein-Barr, herpes simplex, and human herpes-6 viral infections and coinfections on cytokine synthesis. A comparative study","volume":"149","author":"Gosselin","year":"1992","journal-title":"J Immunol"},{"key":"10.1016\/j.trsl.2012.12.012_bib111","doi-asserted-by":"crossref","first-page":"S92","DOI":"10.1016\/S1386-6532(06)70019-1","article-title":"Human herpesvirus 6 reactivation and inflammatory cytokine production in patients with drug-induced hypersensitivity syndrome","volume":"37","author":"Yoshikawa","year":"2006","journal-title":"J Clin Virol"},{"key":"10.1016\/j.trsl.2012.12.012_bib112","doi-asserted-by":"crossref","first-page":"4776","DOI":"10.1128\/JVI.06573-11","article-title":"Human CD4+ T cell response to human herpesvirus 6","volume":"86","author":"Nastke","year":"2012","journal-title":"J Virol"},{"key":"10.1016\/j.trsl.2012.12.012_bib113","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.jinf.2008.06.014","article-title":"Elevated serum cytokine levels are associated with human herpesvirus 6 reactivation in hematopoietic stem cell transplantation recipients","volume":"57","author":"Fujita","year":"2008","journal-title":"J Infect"},{"key":"10.1016\/j.trsl.2012.12.012_bib114","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1002\/lt.21304","article-title":"Human herpesvirus 6 infection in adult living related liver transplant recipients","volume":"14","author":"Ohashi","year":"2008","journal-title":"Liver Transpl"},{"key":"10.1016\/j.trsl.2012.12.012_bib115","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/1471-2334-10-49","article-title":"Is the drug-induced hypersensitivity syndrome (DIHS) due to human herpesvirus 6 infection or to allergy-mediated viral reactivation? Report of a case and literature review","volume":"10","author":"Gentile","year":"2010","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.trsl.2012.12.012_bib116","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2332\/allergolint.55.1","article-title":"Drug-induced hypersensitivity syndrome (DIHS): a reaction induced by a complex interplay among herpes viruses and antiviral and anti-drug immune responses","volume":"55","author":"Shiohara","year":"2006","journal-title":"Allergol Int"},{"key":"10.1016\/j.trsl.2012.12.012_bib117","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1086\/520307","article-title":"High incidence of active Cytomegalovirus infection among septic patients","volume":"26","author":"Kutza","year":"1998","journal-title":"Clin Inf Dis"},{"key":"10.1016\/j.trsl.2012.12.012_bib118","first-page":"865","article-title":"Multiple drug allergies in patients with cutaneous adverse drug reactions diagnosed by in\u00a0vitro drug-induced interferon-gamma release","volume":"10","author":"Halevy","year":"2008","journal-title":"Isr Med Assoc J"}],"container-title":["Translational Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1931524412004483?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1931524412004483?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,6,28]],"date-time":"2023-06-28T18:28:42Z","timestamp":1687976922000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1931524412004483"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,5]]},"references-count":118,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2013,5]]}},"alternative-id":["S1931524412004483"],"URL":"https:\/\/doi.org\/10.1016\/j.trsl.2012.12.012","relation":{},"ISSN":["1931-5244"],"issn-type":[{"value":"1931-5244","type":"print"}],"subject":[],"published":{"date-parts":[[2013,5]]}}}